PharmaNest accelerates the discovery and development of novel anti-fibrotic therapies and related diagnostics

It all started when…

It all started when PharmaNest set out to quantify fibrosis — not as a static scar, but as a living, evolving signature of tissue remodeling. From that vision came FibroNest™, a platform built to measure every collagen fiber, decode its structure, and translate microscopic architecture into actionable biomarkers for drug discovery and clinical care.

Then came FibroMAP™ — born from the need to go deeper, beyond quantification, into discovery. By mapping millions of fibers into phenotypic clusters, FibroMAP reveals the hidden biological patterns that connect preclinical and clinical fibrosis.

What truly defines PharmaNest, though, is not just technology, but collaboration. Every project begins with dialogue — listening to scientists, clinicians, and partners to understand their questions, their data, their vision. From early discovery teams to late-stage clinical developers, we co-design studies, interpret patterns together, and uncover new fibrosis phenotypes that guide translational insight.

That closeness — scientific partnership and customer intimacy — is how FibroNest and FibroMAP evolved: one fiber, one collaboration, one discovery at a time.